Blood Proteins Linked to Early Prostate Cancer Risk

A study led by researchers at Oxford Population Health has found that specific proteins in the blood may signal an increased risk of prostate cancer, including aggressive forms, as early as a decade before a diagnosis.

The proteins, associated with immune responses, cell adhesion, blood vessel growth, and known prostate cancer genes, were linked to future cancer risk in participants. These findings suggest potential biomarkers for early detection.

Experts note that identifying such proteins could improve screening strategies, allowing for earlier intervention. However, further research is needed to validate these markers in larger populations.

Based on reporting from Medical Xpress (Cancer).

Source: Medical Xpress (Cancer). This article was drafted by AI from that reporting and reviewed by an automated accuracy check before publishing.